Christine Colvis

Christine Colvis joined NCATS in June 2012 to lead the “NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules” that tests a new model for public-private partnership collaborations including template agreements to shorten the time it takes to establish collaborations between an academic institution and a pharmaceutical company and move more rapidly into the actual research. Collaborations established between academic institutions and the company will test ideas for new therapeutic uses, with the ultimate goal of identifying promising new treatments for patients. A high level of interest in the program led to the availability of additional pharmaceutical company assets and NCATS funding opportunities including expansion of the program to support development for pediatric indications. Christine also oversees the NCATS Biomedical Data Translator program, which launched in 2016 with an initiative to assess feasibility and architectural design of a system that would enable new insights into the biology of disease in order to improve translation and deliver more treatments to more patients more quickly.